Basic information Display titleGanglioside GD2 a novel beneficial goal in triplenegative breast cancer Default sort keyGanglioside GD2 a novel beneficial goal in triplenegative breast cancer Page length (in bytes)3,751 Page ID364160 Page content languageen - English Page content modelwikitext Indexing by robotsAllowed Number of redirects to this page0 Page protection EditAllow all users (infinite) MoveAllow all users (infinite) View the protection log for this page. Edit history Page creator130.185.159.244 (talk) Date of page creation02:02, 10 April 2023 Latest editor130.185.159.244 (talk) Date of latest edit02:02, 10 April 2023 Total number of edits1 Total number of distinct authors1 Recent number of edits (within past 90 days)0 Recent number of distinct authors0